Clinical Study
Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial Disease
Table 1
Patient characteristics.
| Parameters | |
| Gender (male/female) (%) | 7/5 (58.3/41.7) | Age (years) | 68.6 ± 7.5 | Comorbidities (%) | | Hypertension | 12 (100) | Dyslipidemia | 8 (66.7) | Coronary artery disease | 4 (33.3) | Cerebrovascular disease | 1 (8.3) | Diabetes mellitus | 9 (75) | Chronic kidney disease on hemodialysis | 2 (16.7) | Variables of peripheral arterial disease | | ABI (median [range]) | 0.62 [0.15–1.5] | Rutherford classification (3/4/5) (%) | 8/3/1 (66.7/25.0/8.3) | Biomarkers | | hs-CRP (ng/mL) | 2670.9 ± 5273.4 | SAP (μg/mL) | 39.6 ± 19.9 | PTX3 (ng/mL) | 3.85 ± 3.05 |
|
|
ABI, ankle brachial pressure index; hs-CRP, high-sensitivity C-reactive protein; SAP, serum amyloid P; PTX3, pentraxin 3.
|